Your fact-checks will appear here
Long-term effects of repeated ivermectin dosing for parasitic diseases
The balance of high-quality evidence does not support ivermectin as a proven treatment for : and rigorous reviews have generally found no clear clinical benefit, and major health bodies recommend agai...
Ivermectin is FDA‑approved for a small set of parasitic indications in humans—oral tablets for certain internal worms and topical formulations for external parasites and some skin conditions—but it is...
is an antiparasitic medicine approved in humans for a small set of (oral formulations) and for certain topical ; dosing is weight‑based and usually given as a single oral dose for most indications, wi...
Ivermectin can cause common, usually mild adverse effects such as headache, nausea, dizziness, diarrhea, and skin rash when given at approved human doses . Serious but rare harms include neurological ...
A standard human ivermectin dose for many indications is weight‑based, commonly about 200 micrograms (0.2 mg) per kilogram (kg) of body weight as a single oral dose (, /) . Converting 222 pounds to ki...
share the same active molecule and similar antiparasitic targets, but they differ sharply in absorption, distribution, and clinical use: topical formulations concentrate drug in the skin to exploit lo...
Ivermectin dosing in humans is disease-specific and weight‑based: standard microgram-per-kilogram regimens range from about 150–200 µg/kg for onchocerciasis, strongyloidiasis and enterobiasis, to 400 ...
Ivermectin dosing for human parasitic infections is weight-based and generally expressed in micrograms per kilogram (mcg/kg); the usual therapeutic range for common infections is about 150–200 mcg/kg ...
Ivermectin dosing for human parasitic infections is weight-based, most commonly prescribed at about 200 micrograms per kilogram (mcg/kg) as a single oral dose for strongyloidiasis and many scabies reg...
A focused search of the recent reporting and trial registries shows a small, active clinical program testing ivermectin in combination with immunotherapy for metastatic triple‑negative breast cancer —...
Ivermectin dosing is weight‑based, typically calculated in micrograms per kilogram and most often given as a single oral dose; common regimens for human parasitic infections fall between about 150 and...
Short-term ivermectin use at approved doses is generally associated with mild, self-limited effects — dizziness, headache, gastrointestinal upset, and transient skin reactions — while rare but serious...
(RCTs) and multiple have examined and, taken together, the higher‑quality, larger trials and updated meta‑analyses find no convincing benefit on mortality, hospitalization, or major clinical endpoints...
Poison control centers across the United States reported a clear rise in human ivermectin exposure calls beginning in late 2020 and accelerating in 2021, with national and state-level data showing mul...
Human safety data for subcutaneous (SC) or intramuscular (IM) ivermectin intended for injection are extremely limited: a handful of case reports and small pharmacokinetic observations describe compass...
Randomized and observational studies have tested five‑day ivermectin regimens almost exclusively in the context of COVID‑19, producing a patchwork of contradictory results: small trials from Banglades...
(RCTs) testing ivermectin for prevention or treatment of COVID‑19 are numerous but heterogenous in size, quality, dosing and endpoints; higher‑quality, well‑powered RCTs and recent systematic reviews ...
is a broad‑spectrum antiparasitic (an endectocide) used in both human and veterinary medicine; the same active compound can appear in tablets, topical creams, injectables, pastes and “pour‑on” product...
is an antiparasitic medicine for several human parasitic infections—primarily , intestinal strongyloidiasis and other helminthiases, and in some regimens for and lice—and is available in oral and topi...
Veterinary authorities and product labels recommend dosing primarily by species and body weight, expressed as micrograms or milligrams per kilogram; common target ranges are about 100–600 mcg/kg depen...